Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess pop...

Podrobná bibliografie
Hlavní autoři:	Dong Li, Hairong Zhang, Na You, Zhifei Chen, Xiuhui Yang, Hangsu Zhang, Yong Zhou, Ningxuan Zheng, Weiyi Pan
Médium:	Článek
Jazyk:	English
Vydáno:	Taylor & Francis Group 2022-11-01
Edice:	Human Vaccines & Immunotherapeutics
Témata:	mumps seroprevalence vaccination measles-mumps-rubella vaccine (mmr) geometric mean concentration (gmc)
On-line přístup:	http://dx.doi.org/10.1080/21645515.2022.2096375

Podobné jednotky

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
Autor: L Sticchi, a další
Vydáno: (2019-12-01)

Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina
Autor: Carla Vizzotti, a další
Vydáno: (2023-03-01)

Factors associated with mumps meningitis and the possible impact of vaccination
Autor: Kyuyol Rhie, a další
Vydáno: (2016-01-01)

Low Prevalence of Mumps IgG Antibodies among the Paediatric Population Attending Tertiary Care Hospital in Southern India- A Pilot Study
Autor: Aridass Dhanasezhian, a další
Vydáno: (2023-06-01)

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA
Autor: Amy Parker Fiebelkorn, a další
Vydáno: (2013-09-01)

Emergent lineages of mumps virus suggest the need for a polyvalent vaccine
Autor: Meghan May, a další
Vydáno: (2018-01-01)

Mumps Vaccine Effectiveness Against Orchitis
Autor: Susan Hahné, a další
Vydáno: (2012-01-01)

Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin
Autor: Andrea A. Berry, a další
Vydáno: (2017-07-01)

Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study
Autor: Yuanbao Liu, a další
Vydáno: (2018-05-01)

Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study
Autor: The MMR-162 Study Group
Vydáno: (2018-12-01)

High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China
Autor: Xiang Sun, a další
Vydáno: (2020-07-01)

Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection
Autor: Sara Mercader, a další
Vydáno: (2018-10-01)

Measles, mumps and rubella vaccination coverage in capitals and interior region municipalities of Northeast Brazil: a household survey in a cohort of children born in 2017 and 2018
Autor: Adjoane Mauricio Silva Maciel, a další
Vydáno: (2024-12-01)

Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines
Autor: Md Ahsan Habib, a další
Vydáno: (2023-01-01)

Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University
Autor: Maryam Keshavarz, a další
Vydáno: (2016-06-01)

Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, Canada
Autor: Wallis Rudnick, a další
Vydáno: (2022-01-01)

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults
Autor: Patricia Kaaijk, a další
Vydáno: (2022-01-01)

Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England
Autor: Cheryl Cohen, a další
Vydáno: (2007-01-01)

Seroconversion rates following 2 doses of measles- mumps- rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age
Autor: Hana Saffar, a další
Vydáno: (2022-01-01)

Mumps Outbreak among Highly Vaccinated Teenagers and Children in the Central Region of Portugal, 2012-2013
Autor: Eugénio Cordeiro, a další
Vydáno: (2015-08-01)

Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart
Autor: Abbas Zamanian, a další
Vydáno: (2014-01-01)

Raising Epidemiological Awareness: Assessment of Measles/MMR Susceptibility in Highly Vaccinated Clusters within the Hungarian and Croatian Population—A Sero-Surveillance Analysis
Autor: Dávid Szinger, a další
Vydáno: (2024-05-01)

Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy
Autor: Brunella Perfetto, a další
Vydáno: (2024-03-01)

Intralesional Injection of the Measles–Mumps–Rubella Vaccine into Resistant Palmoplantar Warts: A Randomized Controlled Trial
Autor: Mohammad Sadegh Rezai, a další
Vydáno: (2019-01-01)

Outbreaks of mumps: an observational study over two decades in a single hospital in Korea
Autor: Ji-Ung Ryu, a další
Vydáno: (2014-09-01)

Methicillin-resistant Staphylococcus Aureus Bacteraemia in a Young Boy following Mumps Infection: A Case Report
Autor: Jayakanthan Saravanan, a další
Vydáno: (2025-01-01)

Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time
Autor: Ousseny Zerbo, a další
Vydáno: (2020-12-01)

Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
Autor: Eliane Matos dos Santos, a další
Vydáno: (2014-06-01)

Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China
Autor: Danni Wang, a další
Vydáno: (2021-07-01)

One single-center serological survey on measles, rubella and mumps antibody levels of people in Youyang, China
Autor: Qing Wang, a další
Vydáno: (2021-11-01)

Longitudinal Characterization of the Mumps-Specific HLA-A2 Restricted T-Cell Response after Mumps Virus Infection
Autor: Josien Lanfermeijer, a další
Vydáno: (2021-12-01)

Questionable Immunity to Mumps among Healthcare Workers in Italy—A Cross-Sectional Serological Study
Autor: Cristiana Ferrari, a další
Vydáno: (2024-05-01)

Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands
Autor: Regnerus A. Vos, a další
Vydáno: (2019-10-01)

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
Autor: Manlio Fusciello, a další
Vydáno: (2022-06-01)

Severe pneumococcal pneumonia following Measles- Mumps- Rubella vaccination / Pneumonie pneumococică severă dezvoltată ca urmare a vaccinării Rujeolă-Oreion-Rubeolă
Autor: Gál Orsolya, a další
Vydáno: (2016-09-01)

Domestic Tetravaccine (Measles-Rubella-Mumps) – Immunization of Premature Babies
Autor: V. V. Semerikov, a další
Vydáno: (2022-09-01)

Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017
Autor: Angela Guo, a další
Vydáno: (2023-12-01)

Two cases of measles after vaccination with measles mumps and rubella combined live attenuated vaccine
Autor: SHEN Jinhua, a další
Vydáno: (2022-05-01)

Dynamics of maternally transferred antibodies against measles, mumps, and rubella in infants in Sri Lanka
Autor: Nadhikala Muthiah, a další
Vydáno: (2021-06-01)

Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era
Autor: Malorie Perry, a další
Vydáno: (2023-03-01)